Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
US |
|
A
|
AAPICO Hitech PCL
SET:AH
|
TH |
|
Replimune Group Inc
NASDAQ:REPL
|
US |
|
W
|
WenYi Trinity Technology Co Ltd
SSE:600520
|
CN |
|
B
|
Bcm Alliance Bhd
KLSE:BCMALL
|
MY |
|
A
|
An Phat Bioplastics JSC
VN:AAA
|
VN |
|
Mattel Inc
NASDAQ:MAT
|
US |
|
L
|
L'Oreal SA
DUS:LOR
|
FR |
|
Bridgestone Corp
F:BGT
|
JP |
|
Tombador Iron Ltd
ASX:TI1
|
AU |
|
I
|
Indofood Sukses Makmur Tbk PT
XBER:ISM
|
ID |
Shareholder Yield
Current shareholder yield for CRVS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CRVS Price
Corvus Pharmaceuticals Inc
| Average Annual Return | 71.66% |
| Standard Deviation of Annual Returns | 97.65% |
| Max Drawdown | -92% |
| Market Capitalization | 1.1B USD |
| Shares Outstanding | 84 090 000 |
| Percentage of Shares Shorted | 25.85% |
